Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.18%38.36B | -1.01%177.62B | -4.43%37.54B | 2.51%179.42B | 0.53%46.91B | 17.57%47.51B | -5.19%45.72B | -1.13%39.28B | 17.61%175.03B | 19.32%46.66B |
| Cost of revenue | 3.27%24.35B | 0.78%115.4B | -4.91%23.57B | 2.41%114.5B | -3.21%30.49B | 16.25%29.47B | -3.10%29.75B | 2.23%24.79B | 17.95%111.81B | 22.61%31.5B |
| Gross profit | 0.32%14.01B | -4.16%62.22B | -3.61%13.97B | 2.69%64.92B | 8.31%16.42B | 19.79%18.04B | -8.86%15.97B | -6.38%14.49B | 17.00%63.22B | 13.02%15.16B |
| Operating expense | -4.27%13.04B | 2.79%53.39B | 9.56%13.62B | 9.68%51.94B | 6.42%13.65B | 9.96%12.8B | 9.83%13.06B | 13.05%12.43B | 15.61%47.35B | 15.00%12.83B |
| Operating profit | 182.51%969M | -31.99%8.83B | -83.31%343M | -18.19%12.98B | 18.68%2.77B | 53.29%5.24B | -48.28%2.91B | -54.10%2.06B | 21.37%15.86B | 3.23%2.33B |
| Net non-operating interest income (expenses) | -16.37%235M | -21.55%1B | 2.18%281M | -7.80%1.28B | -34.25%238M | 3.22%385M | 37.96%378M | -26.67%275M | 305.87%1.38B | 217.54%362M |
| Non-operating interest income | -11.63%304M | -16.51%1.32B | 1.47%344M | -1.31%1.58B | -10.97%341M | 20.97%473M | 15.36%428M | -25.82%339M | 139.10%1.6B | 92.46%383M |
| Non-operating interest expense | 9.52%69M | 4.59%319M | -1.56%63M | 39.91%305M | 390.48%103M | 388.89%88M | -48.45%50M | -21.95%64M | -33.74%218M | -75.29%21M |
| Net investment income | -63.22%281M | 35.43%2.26B | 54.03%764M | -41.84%1.67B | 153.33%360M | 6.21%599M | -85.36%216M | -67.13%496M | 141.43%2.87B | -429.27%-675M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -214M | -58.84%2.87B | 0 | 1,538.35%6.96B | 948.75%6.69B | -123.91%-11M | 97.20%-6M | 742.22%289M | 106.31%425M | 625.00%638M |
| Income from associates and other participating interests | 0 | 0 | -13.33%-34M | -42.61%-164M | 48.28%-30M | -188.24%-49M | -292.86%-55M | -15.38%-30M | -33.72%-115M | -480.00%-58M |
| Special income (charges) | -5,140.54%-3.88B | 81.95%-1.29B | -335.29%-74M | -1,492.00%-7.16B | -1,110.52%-7.02B | 85.85%-58M | -119.10%-68M | -109.24%-17M | -179.23%-450M | -276.62%-580M |
| Less:Restructuring and mergern&acquisition | --3.61B | --0 | ---- | -156.03%-195M | -709.38%-195M | ---- | ---- | ---- | 116.15%348M | -25.58%32M |
| Less:Other special charges | 107.41%56M | -17.02%156M | 58.82%27M | 138.68%188M | 484.21%111M | -37.14%22M | 110.67%38M | 109.24%17M | 45.58%-486M | -50.00%19M |
| Less:Write off | 361.70%217M | -84.14%1.14B | --47M | 1,119.56%7.17B | 1,243.10%7.11B | -38.98%36M | ---- | ---- | 258.54%588M | 624.66%529M |
| Other non-operating income (expenses) | 74.29%183M | 170.87%344M | 250.00%105M | -47.95%127M | -178.16%-68M | 11.49%165M | 0 | 287.50%30M | -48.74%244M | 434.62%87M |
| Income before tax | -275.51%-2.43B | -10.68%14.01B | -55.31%1.38B | -22.45%15.68B | 39.17%2.94B | 52.26%6.27B | -55.17%3.38B | -52.02%3.1B | 28.28%20.22B | -14.89%2.11B |
| Income tax | -63.45%398M | 47.20%7.21B | -16.55%1.09B | -24.95%4.9B | 71.63%841M | 18.14%1.84B | -51.38%915M | -49.79%1.31B | 107.64%6.53B | 744.83%490M |
| Net income | -1,061.56%-2.83B | -36.97%6.8B | -83.59%294M | -21.25%10.78B | 29.34%2.09B | 72.96%4.43B | -56.43%2.46B | -53.53%1.79B | 8.51%13.69B | -33.10%1.62B |
| Net income continuous operations | -1,058.31%-2.83B | -36.97%6.8B | -83.54%295M | -21.26%10.78B | 29.34%2.09B | 72.96%4.43B | -56.44%2.46B | -53.53%1.79B | 8.52%13.69B | -33.10%1.62B |
| Noncontrolling interests | 0 | 0.00%-1M | 0.00%-2M | 83.33%-1M | 133.33%1M | 0 | 0 | 0.00%-2M | -146.15%-6M | -250.00%-3M |
| Net income attributable to the company | -1,051.85%-2.83B | -36.98%6.8B | -83.44%297M | -21.27%10.79B | 29.18%2.09B | 72.72%4.43B | -56.40%2.47B | -53.50%1.79B | 8.67%13.7B | -32.99%1.62B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -1,051.85%-2.83B | -36.98%6.8B | -83.44%297M | -21.27%10.79B | 29.18%2.09B | 72.72%4.43B | -56.40%2.47B | -53.50%1.79B | 8.67%13.7B | -32.99%1.62B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -1,197.95%-32.06 | -27.72%70.27 | -80.99%2.92 | -15.97%97.22 | 46.83%20.38 | 82.28%39.92 | -54.83%21.56 | -52.27%15.36 | 10.67%115.69 | -30.81%13.88 |
| Diluted earnings per share | -1,197.95%-32.06 | -27.72%70.27 | -80.99%2.92 | -15.97%97.22 | 47.95%20.38 | 83.07%39.92 | -54.83%21.56 | -52.27%15.36 | 10.67%115.69 | -31.33%13.7751 |
| Dividend per share | 0 | 40.00%70 | 0 | 0.00%50 | 0.00%50 | 0 | 0 | 0 | 0.00%50 | 0.00%50 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |